Učitavanje...
Novel Disulfide-Bridged Bioresponsive Antisense Oligonucleotide Induces Efficient Splice Modulation in Muscle Myotubes in Vitro
[Image: see text] Splice-modulating antisense therapy has shown tremendous potential in therapeutic development in recent years with four FDA-approved antisense drugs since 2016. However, an efficient and nontoxic antisense oligonucleotide (AO) delivery system still remains as a major obstacle in nu...
Spremljeno u:
| Izdano u: | ACS Omega |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Chemical Society
2020
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7391367/ https://ncbi.nlm.nih.gov/pubmed/32743177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.0c01463 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|